Peptides, from first principles

The definition is only about length

Amino acids are the parts every protein in your body is assembled from — muscle, hair, the enzymes breaking down your last meal. Join them in a specific order with peptide bonds and you have a peptide. Somewhere past about fifty links in the chain we stop saying peptide and start saying protein.

That boundary is a naming convention, not a law of physics, and it leaks. Insulin runs to fifty-one amino acids and almost everyone still calls it a peptide hormone. It has been injected to control blood sugar for roughly a century, which makes it the most thoroughly documented therapeutic peptide in existence. Oxytocin, at nine amino acids, is at the other end of the size range and is involved in labour and social bonding.

Your body already manufactures thousands of these, and they sit somewhere in nearly every biological process you have. The ones sold for health and performance are one of two things: a laboratory copy of something you already make, or an analogue — deliberately altered so it binds harder, survives longer, or resists the enzymes that would otherwise clear it.

Why a peptide is not a steroid

This is the single most common confusion, and the distinction is mechanical rather than semantic.

A steroid is the hormone. Inject testosterone and there is simply more testosterone in you than there was an hour ago; the substance you administered is the substance that acts.

A peptide is a message. It carries no hormonal payload of its own. It instructs cells to do something — release a hormone you already produce, begin a repair process, change how hungry you feel.

The practical consequence is worth stating bluntly, because a lot of marketing depends on people not knowing it: no peptide raises testosterone directly. The closest thing to a muscle-building effect comes from growth hormone secretagogues, and they reach body composition indirectly, by way of IGF-1. What that produces is a modest shift in recovery and composition over months. It is not what anabolic steroids do, and anything marketed as if it were is misrepresenting the mechanism.

What actually happens when one binds

A peptide works by shape. Its three-dimensional structure fits a particular receptor on a cell surface the way a key fits one lock, and that fit is most of what determines what it does and does not affect.

With few exceptions, the receptors involved are G protein coupled receptors. Binding deforms the receptor; the deformation activates a G protein on the inside of the cell; that releases second messengers such as cyclic AMP; those drive enzyme cascades that carry the instruction onward.

Each step multiplies. One occupied receptor can generate a great many downstream molecules, which is why peptides do useful work at microgram doses while a steroid is measured in milligrams. It is also why the specificity matters: a peptide aimed at a repair pathway pushes repair, and largely leaves unrelated systems alone. That selectivity is the entire appeal.

Why almost all of them need a needle

Your digestive tract is, from a peptide's point of view, a machine built to destroy it. Breaking chains of amino acids into individual amino acids for absorption is precisely what the stomach and small intestine are for. Swallow most peptides and they are dismantled long before they reach anything they could bind to.

Subcutaneous or intramuscular injection sidesteps that, putting the molecule into circulation intact. There are exceptions — a few have been engineered to survive the gut, and others are given nasally because they cross mucous membranes — but for most of what is discussed in this index, the needle is not a preference. It is the only route that works.

When they are worth considering

There are three defensible reasons, and they are narrower than the marketing suggests.

• Production has genuinely declined. Growth hormone output falls on the order of 14–15% per decade after roughly age thirty, which tracks with slower recovery and changes in body composition.
• A pathway is underperforming because of injury, sustained stress, or genetics — not because it is being neglected.
• You want to push a normal process faster than it would otherwise run, such as shortening a healing timeline.

Translated into practice: consider them if you are already training and eating consistently and have genuinely stalled; if an injury has refused to resolve under competent treatment; or if age-related decline is measurable rather than assumed.

The categories, and what the evidence carries

Grouped by what they are used for, with the grade this site would apply to the headline claim in each group. Grades describe published human evidence only. A high grade means the research is solid; it says nothing about whether a given compound is appropriate, legal, or safe for you.

Two entries are worth pulling out. The GLP-1 agonists and bremelanotide are approved drugs with large randomised trials behind them — that is why they grade A. BPC-157 and TB-500 grade D not because they are considered useless, but because the supporting work is almost entirely in animals. The gap between how confidently BPC-157 is marketed and how little human data exists is the widest on this page.

What to actually expect

The reports below are what users and practitioners commonly describe. They are not trial results, and no one is collecting them systematically. On this site's rubric that is Grade D — anecdote. It is included because it is the most common question, and because knowing the shape of a typical timeline is useful even when the evidence behind it is weak.

A fuller breakdown of when each kind of change would plausibly show up is in the selection primer.

Three things that consistently surprise people:

• The commitment is real. Most protocols mean injecting daily or several times a week for months, plus learning reconstitution, cold storage, and sterile technique. Some require cycling to avoid blunting the response.
• Healing peptides do not repair structure. A tear that needs surgical repair still needs surgery.
• GLP-1 appetite suppression is not a habit. It is genuinely powerful, and it stops when the drug stops. People who do not build durable eating patterns during treatment tend to regain the weight afterwards.

The part most guides leave out

Mechanism and evidence are only half the picture. Regulatory status is the other half, and it varies enormously between compounds that get discussed in the same breath.

• Some are approved medicines. Semaglutide, tirzepatide, and bremelanotide are prescription drugs, approved for specific indications, obtained through a clinician.
• Most are not. A large share of what is sold online ships labelled for research use only, not for human consumption. That phrase is the seller's legal position. It is not a safety assurance, and it is not a dosing instruction.
• BPC-157 is specifically restricted. In 2023 the FDA placed it in the category of substances judged to pose significant safety risks in compounding, which removed the legitimate compounding-pharmacy route in the US.
• Quality is not guaranteed. Outside regulated pharmaceutical supply, purity, sterility, and whether the vial contains the stated amount all depend entirely on the vendor. Independent third-party assay results are the only meaningful check, and you should expect to see them before buying.
• Competitive athletes: assume banned. Growth hormone secretagogues and most repair peptides sit on the WADA prohibited list. Check the current list against your sport before, not after.

Before you act on any of this

References

1. StatPearls. Biochemistry, Peptide. NCBI, 2023.
2. StatPearls. Biochemistry, G Protein Coupled Receptors. NCBI, 2023.
3. Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions. Drug Discovery Today, 2015.
4. Transmembrane Signal Transduction by Peptide Hormones. Frontiers in Pharmacology, 2015.
5. Second Messengers. Cold Spring Harbor Perspectives in Biology, 2016.
6. Institute for Molecular Bioscience, University of Queensland. Explainer: peptides vs proteins. 2020.
7. National Human Genome Research Institute. Peptide.
8. ScienceDirect. Peptide Receptor — overview.
9. US FDA. Bulk Drug Substances Nominated for Use in Compounding Under Section 503A — Category 2. 2023.
10. World Anti-Doping Agency. Prohibited List. Current edition.

Citations support the mechanism and definitions above. The category grades are this site's own assessment and are re-reviewed as new trials publish.

Back to the index